Benjamin Graham · Investimento deep-value defensivo
Is ACADIA Pharmaceuticals Inc. (ACAD) a Benjamin Graham Stock?
Meets 5/7 Graham criteria, partially qualifies.
49/100
Não encaixa
5/7 critérios atendidos
Os critérios de Benjamin Graham, aplicados a ACAD
P/E ≤ 15
chave9.6x
P/B ≤ 1.5
chave2.9x
Current ratio ≥ 2
3.6x
Debt / Equity ≤ 1
0.0x
Como ACAD pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$3.44B
P/L (TTM)
9.6x
ROIC (TTM)
6.17%
Margem bruta
91.47%
Outras análises Benjamin Graham
Perguntas frequentes
What is ACAD's Benjamin Graham fit score?
ACAD scores 49/100 on our Benjamin Graham fit engine. Meets 5/7 Graham criteria, partially qualifies.
Does Benjamin Graham actually own ACAD?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends ACAD.
How often is this score updated?
ACAD's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Benjamin Graham possua ou recomende ACAD pessoalmente.
